Its activation triggers senescence and immunogenicity in hormone receptor-positive tumor models such as BT474, MCF7, and HER2 cells, and induces metabolic collapse and stemness inhibition in triple-negative breast cancer (TNBC). The gene discussed is NR4A1; the disease is triple-negative breast carcinoma.